Schedule 13D ownership disclosure
CARTESIAN THERAPEUTICS INC
Security class unavailable · CUSIP: 816212104
Event date: 2017-08-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,849,371
- Percent of class
- 8.3800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-17-000645
- Form type
- SC 13D
- Filer
- ORBIMED ADVISORS LLC
- CIK
- CIK 1055951
- Filed
- Aug 15, 2017
- Reporting period
- Aug 11, 2017
- Description
- Schedule 13D beneficial ownership